Table 2 Patients’ characteristics
From: Clinical relevance of aortic calcification in urolithiasis patients
| Â | Non-stone group | Stone group | P value |
|---|---|---|---|
n | 148 | 292 | Â |
Age (years) | 62 (54–72) | 63 (54–72) | 0.626 |
Sex (Male), n= | 89 (60%) | 169 (58%) | 0.683 |
Body mass index (kg/m2) | 24 ± 4 | 25 ± 4 | 0.171 |
Comorbidities | |||
Hypertension, n= | 43 (29%) | 142 (49%) | <0.001 |
Diabetes, n= | 31 (21%) | 72 (25%) | 0.407 |
Cardiovascular disease, n= | 20 (14%) | 33 (11%) | 0.536 |
eGFR (ml/min/1.73 m2) | 72 (61–87) | 76 (58–95) | 0.250 |
Hyperuricemia (>7.0Â mg/dL, n= | 24 (16%) | 45 (15%) | 0.890 |
Dyslipidemia (total cholesterol >220, or triglyceride >140Â mg/dL), n= | 15 (10%) | 31 (11%) | 1.000 |
Voluntary urine protein > 30 mg/dL, n= | 22 (15%) | 57 (20%) | 0.240 |
Type of stone | |||
 Uric acid stone, n= |  | 32 (11%) |  |
 Non-uric acid stone, n= |  | 216 (74%) |  |
 Unknown, n= |  | 44 (15%) |  |
Aortic calcification index (ACI) | 6.7 (0.8–19.2) | 7.1 (0.8–22.5) | 0.856 |